| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/25/2013 | EP2640412A1 Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 09/25/2013 | EP2640411A1 Anti-inflammatory compositions |
| 09/25/2013 | EP2640410A1 Composition comprising a peptide and an inhibitor of viral neuraminidase |
| 09/25/2013 | EP2640409A1 A synergistic composition of plant extracts for treating skin diseases involving abnormal cell growth |
| 09/25/2013 | EP2640408A2 Keratin compositions for treatment of bone deficiency or injury |
| 09/25/2013 | EP2640407A1 Method for increasing neprilysin expression and activity |
| 09/25/2013 | EP2640406A1 Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins |
| 09/25/2013 | EP2640405A2 Human-adapted ha polypeptides, vaccines, and influenza treatment |
| 09/25/2013 | EP2640399A2 Methods and compositions for modulating pd1 |
| 09/25/2013 | EP2640377A1 Fgfr1 extracellular domain combination therapies |
| 09/25/2013 | EP2640350A2 Compositions and methods for hair growth |
| 09/25/2013 | EP2275119B1 Stable isotonic lyophilized protein formulation |
| 09/25/2013 | CN103328648A Peptide with safer secondary structure, peptide library, and production methods for same |
| 09/25/2013 | CN103328646A Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins |
| 09/25/2013 | CN103328514A Protein complexes for antigen binding and methods of use |
| 09/25/2013 | CN103328501A Novel biomarker and uses thereof in diagnosis, treatment of autism |
| 09/25/2013 | CN103328499A Immune-modulating agents and uses therefor |
| 09/25/2013 | CN103328496A Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 09/25/2013 | CN103328460A Derivatives of glyco-CF2-serine and glyco-CF2-threonine |
| 09/25/2013 | CN103328026A Preservative-free follicle stimulating hormone solution delivery device |
| 09/25/2013 | CN103328006A Preparation comprising insulin, nicotinamide and an amino acid |
| 09/25/2013 | CN103328000A A process for reduction and/or removal of FXI and FXIa from solutions containing said coagulation factors |
| 09/25/2013 | CN103327999A Composition for promoting lipolysis |
| 09/25/2013 | CN103327998A Moesin fragments associated with aplastic anemia |
| 09/25/2013 | CN103327997A Moesin modulators and uses thereof |
| 09/25/2013 | CN103327996A Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same |
| 09/25/2013 | CN103327987A Extract of aquatic animal cartilage |
| 09/25/2013 | CN103327828A Method for inhibiting pathogens using a nutritional composition |
| 09/25/2013 | CN103320472A Method for producing endomorphin 2 via high-efficiency expression, and application for same |
| 09/25/2013 | CN103320459A Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 09/25/2013 | CN103320412A Application of deep-sea lysozyme in inhibiting medicament-resistant staphylococcus aureus |
| 09/25/2013 | CN103320405A Method for preparing siganus oramin L-amino acid oxidase recombination protein and purpose thereof |
| 09/25/2013 | CN103319732A Preparation method and application of hydrogel based on rhabdovirus |
| 09/25/2013 | CN103319610A Novel recombinant fusion protein, preparation method and use thereof |
| 09/25/2013 | CN103319609A Human basic fibroblast growth factor (hbFGF) fusion gene and application thereof |
| 09/25/2013 | CN103319608A Pig IFNalpha1-Fc fusion protein as well as encoding gene and expression method thereof |
| 09/25/2013 | CN103319606A Liver targeted peptide-recombinant human endostatin fusion protein, and preparation method and application thereof |
| 09/25/2013 | CN103319605A Hepatic targeting peptide and angiogenesis inhibitor fusion protein as well as preparation method and application thereof |
| 09/25/2013 | CN103319590A Application of Chlamys farreri peptidoglycan recognition protein (CfPGRP-S1) |
| 09/25/2013 | CN103319589A Preparation method of bioactive peptide for inhibiting stomach cancer stem cell proliferation |
| 09/25/2013 | CN103319588A Method for extracting galectin-3 from ranid and preparation thereof |
| 09/25/2013 | CN103319586A Antimicrobial peptide MP1102 of anti-drug resistance staphylococcus aureus and preparation method and application thereof |
| 09/25/2013 | CN103319568A Non-protein amino acid antibacterial peptide and application for same |
| 09/25/2013 | CN103319567A Tripeptide compound and preparation method and applications thereof |
| 09/25/2013 | CN103319554A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/25/2013 | CN103316356A Recombinant lentivirus vector preparation |
| 09/25/2013 | CN103316345A Use melanocortins to treat insulin sensitivity |
| 09/25/2013 | CN103316333A Recombinant human lysozyme with broad-spectrum tumor cell killing activity and its application |
| 09/25/2013 | CN103316332A Simple and convenient senile plaque removal plaster |
| 09/25/2013 | CN103316331A Application of SOD (Superoxide Dismutase) in preparation of medicines for treating skin diseases and pharmaceutical composition thereof as well as application and preparation method of pharmaceutical composition |
| 09/25/2013 | CN103316330A Formula and purposes of soft tissue trauma nursing material |
| 09/25/2013 | CN103316329A Calcitonin polyion micelle composition |
| 09/25/2013 | CN103316328A EGF (Epidermal Growth Factor) collaborative symbiont capable of maintaining activity of EGF for long term and preparation method of EGF collaborative symbiont |
| 09/25/2013 | CN103316327A Application of krait venom antibacterial peptide in preparation of medicine for resisting inflammatory factor |
| 09/25/2013 | CN103316326A Pharmaceutical cyclosporin composition |
| 09/25/2013 | CN103315969A Caspofungin preparation with low impurity content as well as preparation method and use thereof |
| 09/25/2013 | CN103315966A Caspofungin acetate pharmaceutical composition for injection and preparation method thereof |
| 09/25/2013 | CN103315954A Compositions and methods for making and using nanoemulsions |
| 09/25/2013 | CN103315949A Thymopent aqueous solution preparation and use thereof |
| 09/25/2013 | CN102698248B Medicine composition prepared from alanyl glutamine and compound amino acid by utilizing spray drying method |
| 09/25/2013 | CN102648978B Stable protein pharmaceutical preparation and preparation method thereof |
| 09/25/2013 | CN102631665B Pharmaceutical composition of alanyl glutamine injection and compound amino acid injection |
| 09/25/2013 | CN102526705B Application of human ribosomal protein L23 label peptide in preparation of anti-cancer medicines |
| 09/25/2013 | CN102485748B Oligopeptides with targeting thrombolytic activity, preparation method thereof, and application thereof |
| 09/25/2013 | CN102485747B Oligopeptides with targeting thrombolytic activity, preparation method and application thereof |
| 09/25/2013 | CN102477077B Boc-Pro-Ala-Lys-Lys(Pro-Ala-Lys)-OCH2(CH2)nCH3, synthesis method and application thereof as thrombus dissolving agent |
| 09/25/2013 | CN102477074B Oligopeptide compound and preparation method and application thereof |
| 09/25/2013 | CN102477071B Pro-Ala-Lys-Lys(Pro-Ala-Lys)-Asp[OCH2(CH2)nCH3]-OCH2(CH2)nCH3, synthesis method and application thereof as thrombus dissolving agent |
| 09/25/2013 | CN102477070B Oligopeptide with thrombus dissolving activities and preparation method and application thereof |
| 09/25/2013 | CN102441160B Thymosin alpha1 medicinal composition and preparation method thereof |
| 09/25/2013 | CN102440957B Terlipressin acetate nasal cavity spray and preparation method thereof |
| 09/25/2013 | CN102423482B preparation method of compound amlodipine-lisinopril tablets |
| 09/25/2013 | CN102405935B Protamine compounded preparation, preparation method and application thereof |
| 09/25/2013 | CN102276695B Polypeptide with function of lowering blood pressure and application thereof |
| 09/25/2013 | CN102188391B Method for preparing granulocyte-macrophage colony stimulating factor microsphere |
| 09/25/2013 | CN102178931B Recombinant human interleukin-12 preparation for injection and preparation method thereof |
| 09/25/2013 | CN101972471B Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof |
| 09/25/2013 | CN101954071B Use of ulinastatin in preparation of medicament for treating systemic lupus erythematosus and medicinal composition of ulinastatin |
| 09/25/2013 | CN101897974B Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins |
| 09/25/2013 | CN101773661B 3-ether and 3-thioether substituted cyclosporin derivatives for treatment and prevention of hepatitis c infection |
| 09/25/2013 | CN101724016B Peptide compound and preparation method and application thereof |
| 09/25/2013 | CN101578103B Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 09/25/2013 | CN101475636B Human interferon-like protein and use thereof |
| 09/25/2013 | CN101374536B Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 09/24/2013 | US8541628 cytofectins; delivering an anionic molecule into a cell by complexing with cationic lipids of invention |
| 09/24/2013 | US8541579 Substituted diketopiperazines as oxytocin antagonists |
| 09/24/2013 | US8541551 Immunogen and antivenom against violin spider venom |
| 09/24/2013 | US8541550 Methods and compositions for delivering polynucleotides |
| 09/24/2013 | US8541549 Annexin-based apoptosis markers |
| 09/24/2013 | US8541548 Delivering nucleic acids to cells; complexing nucleic acid with polyampholte; contacting cell; biocompatible in vivo delivery; gene therapy |
| 09/24/2013 | US8541547 Methods and compositions for tumor vaccination and therapy |
| 09/24/2013 | US8541546 WDRPUH epitope peptides and vaccines containing the same |
| 09/24/2013 | US8541545 Stabilized melanocortin ligands |
| 09/24/2013 | US8541390 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/24/2013 | US8541384 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer |
| 09/24/2013 | US8541379 Kokumi-imparting agent |
| 09/24/2013 | US8541378 Recombinant albumins fused with poly-cysteine peptide and the methods for preparing the same |
| 09/24/2013 | US8541377 Optimized dengue virus entry inhibitory peptide (DN81) |
| 09/24/2013 | US8541376 Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 09/24/2013 | US8541375 Glycopeptide phosphonate derivatives |